These models can test the efficacy of available drugs or develop new ones (Boston)—Cystic fibrosis (CF) is caused by a mutation of the CFTR gene. While there are many hundreds of known mutations, not all of them are currently treatable which means a significant number of CF patients lack targeted therapies. In an effort to […]
We are pleased to announce the extension of the Insights to Inspire program – Conversations Toward Solutions workshops. These three workshops are designed to explore the experiences and challenges hubs have faced with common data issues across the consortium. Many hubs experience common problems and each hub has established ways of dealing with that problem. […]
the University of Rochester (UR) is hosting the I-Corps@NCATS Regional Short Course this fall, which is specifically designed for biomedical scientists, clinician scientists, and engineers to provide them with a new approach to accelerate the translation of their discoveries from the lab to clinical practice. This program, supported by the NIH National Center for Advancing […]
Helping to Accelerate Research Potential (HARP) (UE5 – Clinical Trial Not Allowed) 07/28/2022 The purpose of this Funding Opportunity Announcement (FOA) is to support mentors who will develop educational activities and provide appropriate mentoring to NIDDK scholars and early career individuals from diverse backgrounds, including those from groups underrepresented in biomedical, behavioral, clinical, and social […]
(Boston)—Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading cause of chronic liver disease, affecting more than 25 percent of the U.S. and global population. One in four individuals with NAFLD have nonalcoholic steatohepatitis—a type of liver disease in which fat builds up in the liver of people who drink little or no […]
The PROVIDENCE/BOSTON Center for AIDS Research (CEAR) is Offering a six month proposal development curriculum for post-doctoral fellows and junior faculty planning to submit K award application on HIV/AIDS to NIH for funding. This six-month proposal development curriculum is characterized by milestone driven progress and formal review by an advisory board of 3-5 advisors. Trainees will […]
Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes (T1D) Research (U01 Clinical Trial Not Allowed) 07/14/2022 06:20 PM EDT This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing the development and/or validation of targeted mass spectrometric assays (e.g. Multiple Reaction Monitoring) for proteins and peptides […]
Social media analytics can assist clinical practice decisions for plastic surgeons as they discuss procedures with their patients (Boston)—With the changing societal body image in America, plus size models have gained in popularity and positively impacted a body inclusive model of beauty. As such, plastic surgeons will likely see an increased demand for procedures that […]
Largest Longitudinal Assessment of Patients Over 25 years Treated with Stem Cell Transplantation for Rare Disease (Boston)—AL amyloidosis is a life-threatening disease related to bone marrow cancer, multiple myeloma. It is caused when a person’s antibody-producing white blood cells (i.e. plasma cells) do not function properly and generate abnormal protein which misfolds to form amyloid […]
(Boston)—Andrew Berical, MD, Assistant Professor of Medicine at Boston University School of Medicine (BUSM), is the recipient of the Harry Shwachman Clinical Investigator Award from the Cystic Fibrosis Foundation (CFF). The four-year, $390,000 grant will fund Berical’s research “A multi-omic and genetically-controlled assessment of iPSC-derived airway cells to advance therapies for CF.” The award provides […]